RLAY
Relay Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$19.04
+0.16%Aug 7, 2026, 00:12 UTC
Relay Therapeutics, Inc. reported a second-quarter loss of $0.41 per share, in line with the Zacks Consensus Estimate and unchanged from the year-ago quarter.
Source: